Eyegate Pharmaceuticals Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Eyegate Pharmaceuticals Inc.

Eyegate Pharmaceuticals Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Extended Market Index Fund

114,949

0.27%

07/31/2018

10,323

0.02%

09/05/2018

iShares Core S&P Total US Stock Market ETF

635

09/06/2018

View Profile

Address	271 Waverley Oaks Road Waltham Massachusetts 02452 United States
Employees	-
Website	http://www.eyegatepharma.com
Updated	07/08/2019
EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U.